Developing an isotope dilution UHPLC–MS/MS method to quantify linezolid in human plasma: application to therapeutic drug monitoring

Papers of special note have been highlighted as: • of interest

Reference

• 1. Hashemian SM, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Des. Devel. Ther. 12, 1759–1767 (2018).
  Medline CASGoogle Scholar
• 2. Durand GA, Raoult D, Dubourg G. Antibiotic discovery: history, methods and perspectives. Int. J. Antimicrob. Agents 53(4), 371–382 (2019).
  Medline CASGoogle Scholar
• 3. Sazdanovic P, Jankovic SM, Kostic M, Dimitrijevic A, Stefanovic S. Pharmacokinetics of linezolid in critically ill patients. Expert Opin. Drug Metab. Toxicol. 12(6), 595–600 (2016).
  Medline CASGoogle Scholar
• 4. Trotman RL, Williamson JC, Shoemaker DM, Salzer WL. Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy. Clin. Infect. Dis. 41(8), 1159–1166 (2005).
  Medline CASGoogle Scholar
• 5. Stalker DJ, Jungbluth GL. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin. Pharmacokinet. 42(13), 1129–1140 (2003).
  Medline CASGoogle Scholar
• 6. Pea F, Furlanut M, Cojutti P et al. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob. Agents Chemother. 54(11), 4605–4610 (2010).
  Medline CASGoogle Scholar
• 7. Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E, Furlanut M. Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients. J. Antimicrob. Chemother. 67(8), 2034–2042 (2012). • Gives an introduction of necessity of therapeutic drug monitoring for linezolid.
  Medline CASGoogle Scholar
• 8. Cepeda JA, Whitehouse T, Cooper B et al. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. J. Antimicrob. Chemother. 53(2), 345–355 (2004).
  Medline CASGoogle Scholar
• 9. Rayner CR, Forrest A, Meagher AK, Birmingham MC, Schentag JJ. Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin. Pharmacokinet. 42(15), 1411–1423 (2003).
  Medline CASGoogle Scholar
• 10. Smith PF, Birmingham MC, Noskin GA et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Ann. Oncol. 14(5), 795–801 (2003).
  Medline CASGoogle Scholar
• 11. Kishor K, Dhasmana N, Kamble SS, Sahu RK. Linezolid induced adverse drug reactions – an update. Curr. Drug Metab. 16(7), 553–559 (2015).
  Medline CASGoogle Scholar
• 12. Cattaneo D, Orlando G, Cozzi V et al. Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections. Int. J. Antimicrob. Agents 41(6), 586–589 (2013).
  Medline CASGoogle Scholar
• 13. Cattaneo D, Gervasoni C, Cozzi V, Castoldi S, Baldelli S, Clementi E. Therapeutic drug management of linezolid: a missed opportunity for clinicians? Int. J. Antimicrob. Agents 48(6), 728–731 (2016).
  Medline CASGoogle Scholar
• 14. Zoller M, Maier B, Hornuss C et al. Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study. Crit. Care 18(4), 374–385 (2014).
  Google Scholar
• 15. Zander J, Maier B, Zoller M, Teupser D, Vogeser M. Quantification of linezolid in serum by LC–MS/MS using semi-automated sample preparation and isotope dilution internal standardization. Clin. Chem. Lab. Med. 52(3), 381–389 (2014). • The current assay was improved based on this published method.
  Medline CASGoogle Scholar
• 16. La Marca G, Villanelli F, Malvagia S et al. Rapid and sensitive LC–MS/MS method for the analysis of antibiotic linezolid on dried blood spot. J. Pharm. Biomed. Anal. 67–68, 86–91 (2012).
  MedlineGoogle Scholar
• 17. Phillips OA, Abdel-Hamid ME, Al-Hassawi NA. Determination of linezolid in human plasma by LC–MS-MS. Analyst 126(5), 609–614 (2001).
  Medline CASGoogle Scholar
• 18. Satyanarayana Raju T, Vishweshwari Kutty O, Ganesh V, Yadagiri Swamy P. A validated stability-indicating LC method for the separation of enantiomer and potential impurities of Linezolid using polar organic mode. J. Pharm. Anal. 2(4), 272–278 (2012).
  MedlineGoogle Scholar
• 19. Souza E, Felton J, Crass RL, Hanaya K, Pai MP. Development of a sensitive LC–MS/MS method for quantification of linezolid and its primary metabolites in human serum. J. Pharm. Biomed. Anal. 178, 112968 (2020).
  Medline CASGoogle Scholar
• 20. Yin L, Feng Y, Tong J et al. Ultrahigh-throughput absolute quantitative analysis of linezolid in human plasma by direct analysis in real time mass spectrometry without chromatographic separation and its application to a pharmacokinetic study. Anal. Bioanal. Chem. 411(20), 5139–5148 (2019).
  Medline CASGoogle Scholar
• 21. Castoldi S, Cozzi V, Baldelli S, Fucile S, Clementi E, Cattaneo D. Comparison of the ARK immunoassay with high-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of linezolid. Ther. Drug Monit. 40(1), 140–143 (2018).
  Medline CASGoogle Scholar
• 22. Hara S, Uchiyama M, Yoshinari M et al. A simple high-performance liquid chromatography for the determination of linezolid in human plasma and saliva. Biomed. Chromatogr. 29(9), 1428–1431 (2015).
  Medline CASGoogle Scholar
• 23. Hopfgartner G, Bourgogne E. Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. Mass Spectrom. Rev. 22(3), 195–214 (2003).
  Medline CASGoogle Scholar
• 24. Van Dongen WD, Niessen WMA. LC-MS systems for quantitative bioanalysis. Bioanalysis 4(19), 2391–2399 (2012).
  CASGoogle Scholar
• 25. US FDA. Bioanalytical Method Validation Guidance for Industry (2018). http://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf
  Google Scholar
• 26. Nukui Y, Hatakeyama S, Okamoto K et al. High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia. J. Antimicrob. Chemother. 68(9), 2128–2133 (2013).
  Medline CASGoogle Scholar